Castlight Health, inc. (NYSE:CSLT) has been assigned an average rating of “Hold” from the ten research firms that are currently covering the firm, MarketBeat reports. Three research analysts have rated the stock with a sell rating, three have given a hold rating and four have assigned a buy rating to the company. The average twelve-month price objective among brokers that have covered the stock in the last year is $5.18.

A number of equities research analysts have recently commented on CSLT shares. Canaccord Genuity upgraded shares of Castlight Health, inc. from a “hold” rating to a “buy” rating in a research report on Tuesday, October 10th. Zacks Investment Research upgraded shares of Castlight Health, inc. from a “hold” rating to a “buy” rating and set a $4.50 target price for the company in a research report on Monday, October 30th. BidaskClub upgraded shares of Castlight Health, inc. from a “strong sell” rating to a “sell” rating in a research report on Wednesday, September 13th. ValuEngine cut shares of Castlight Health, inc. from a “hold” rating to a “sell” rating in a research report on Thursday, August 10th. Finally, Chardan Capital reduced their target price on shares of Castlight Health, inc. from $6.50 to $6.30 and set a “buy” rating for the company in a research report on Thursday, October 26th.

In other Castlight Health, inc. news, CEO John C. Doyle sold 35,184 shares of the stock in a transaction dated Thursday, August 17th. The shares were sold at an average price of $3.65, for a total transaction of $128,421.60. Following the completion of the transaction, the chief executive officer now owns 75,639 shares of the company’s stock, valued at $276,082.35. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Giovanni M. Colella sold 23,800 shares of the stock in a transaction dated Tuesday, August 15th. The stock was sold at an average price of $4.05, for a total transaction of $96,390.00. Following the transaction, the insider now directly owns 78,906 shares of the company’s stock, valued at approximately $319,569.30. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 158,487 shares of company stock valued at $597,608. 37.43% of the stock is owned by company insiders.

A number of hedge funds have recently made changes to their positions in CSLT. TIAA CREF Investment Management LLC boosted its stake in Castlight Health, inc. by 2.1% during the first quarter. TIAA CREF Investment Management LLC now owns 108,032 shares of the software maker’s stock worth $394,000 after buying an additional 2,210 shares during the period. Vanguard Group Inc. boosted its stake in Castlight Health, inc. by 7.6% during the first quarter. Vanguard Group Inc. now owns 2,673,760 shares of the software maker’s stock worth $9,760,000 after buying an additional 189,359 shares during the period. Geode Capital Management LLC boosted its stake in Castlight Health, inc. by 2.7% during the first quarter. Geode Capital Management LLC now owns 306,367 shares of the software maker’s stock worth $1,118,000 after buying an additional 8,057 shares during the period. Renaissance Technologies LLC boosted its stake in Castlight Health, inc. by 2.3% during the first quarter. Renaissance Technologies LLC now owns 922,800 shares of the software maker’s stock worth $3,368,000 after buying an additional 20,610 shares during the period. Finally, Schwab Charles Investment Management Inc. boosted its stake in Castlight Health, inc. by 6.7% during the first quarter. Schwab Charles Investment Management Inc. now owns 198,594 shares of the software maker’s stock worth $725,000 after buying an additional 12,483 shares during the period. 41.30% of the stock is owned by institutional investors.

ILLEGAL ACTIVITY NOTICE: “Castlight Health, inc. (CSLT) Receives Average Recommendation of “Hold” from Analysts” was published by Daily Political and is the sole property of of Daily Political. If you are viewing this report on another site, it was stolen and reposted in violation of US and international trademark and copyright legislation. The legal version of this report can be viewed at https://www.dailypolitical.com/2017/11/11/castlight-health-inc-cslt-receives-average-recommendation-of-hold-from-analysts.html.

Castlight Health, inc. (NYSE CSLT) opened at $3.95 on Friday. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.94 and a quick ratio of 1.94. Castlight Health, inc. has a 12-month low of $3.05 and a 12-month high of $5.50.

Castlight Health, inc. (NYSE:CSLT) last issued its earnings results on Wednesday, October 25th. The software maker reported ($0.05) EPS for the quarter, beating the Zacks’ consensus estimate of ($0.07) by $0.02. The business had revenue of $34.60 million during the quarter, compared to analysts’ expectations of $34.61 million. Castlight Health, inc. had a negative net margin of 45.14% and a negative return on equity of 32.57%. The company’s quarterly revenue was up 35.7% compared to the same quarter last year. During the same period in the prior year, the business earned ($0.05) earnings per share. research analysts expect that Castlight Health, inc. will post -0.44 earnings per share for the current fiscal year.

About Castlight Health, inc.

Castlight Health, Inc offers a health benefits platform that engages employees to make healthcare decisions, and enables employers to communicate and measure their benefit programs. The Company operates through cloud-based products segment. Its technology offering aggregates data and applies analytics to make healthcare data transparent.

Analyst Recommendations for Castlight Health, inc. (NYSE:CSLT)

Receive News & Ratings for Castlight Health inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Castlight Health inc. and related companies with MarketBeat.com's FREE daily email newsletter.